跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 12,519 条关于
“SOL-002”
全部
12,519
临床试验
5,666
药物
5,680
机构
184
资讯
989
8个月前
Soley Therapeutics Raises $200M Series C to Advance Cell Stress Sensing Platform and AML Drug Candidate
去年
Sol-Gel Technologies Receives Nasdaq Extension to Regain Compliance
去年
Lipum's SOL-116 Shows Promising Phase I Results for Rheumatoid Arthritis Treatment
去年
Ocular Therapeutix Accelerates Axpaxli Wet AMD Trial, Anticipates Topline Data in Q4 2025
去年
Ocular Therapeutix Completes Enrollment in AXPAXLI Wet AMD Trial, Accelerates Second Study
去年
Sol-Gel Technologies Advances SGT-610 for Gorlin Syndrome and SGT-210 for Darier Disease
去年
Ocular Therapeutix Advances AXPAXLI for Wet AMD and Plans NPDR Clinical Trial
5个月前
Sol-Gel Secures Patent Extension for Patidegib Until 2044, Raises $33.1M to Advance Gorlin Syndrome Trial
去年
Sol-Gel Completes Phase 3 Enrollment for Gorlin Syndrome Treatment SGT-610, Targets $300M Peak Revenue
去年
Sol-Gel and Mayne Pharma Announce $16 Million Deal for EPSOLAY and TWYNEO Rights in the U.S.
第 1 页,共 99 页
上一页
下一页